Viewing Study NCT03753685

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search All Studies All Organizations Report Bug
Ignite Creation Date: 2025-12-18 @ 8:35 AM
Ignite Modification Date: 2025-12-18 @ 8:35 AM
Study NCT ID: NCT03753685
Status:
Last Update Posted:
First Post:
Is Possible Gene Therapy: False
Has Adverse Events: False
Brief Title: X-396(Ensartinib) Capsules in ALK-Positive NSCLC Patients With Brain Metastases
Sponsor:
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Contacts Locations Module Design Module Eligibility Module Outcomes Module